Migraine and multiple sclerosis: Epidemiology and approach to treatment

被引:23
作者
Gelfanda, Amy A. [1 ,2 ]
Gelfand, Jeffrey M. [3 ]
Goadsby, Peter J. [2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Div Child Neurol, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol, Headache Ctr, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Neurol, Multiple Sclerosis Ctr, San Francisco, CA USA
关键词
Migraine; Multiple sclerosis; Epidemiology; Headache; Disease-modifying therapy; Neuroimaging; QUALITY STANDARDS SUBCOMMITTEE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; BRAIN-STEM; AMERICAN ACADEMY; CONTROLLED PHASE; ORAL FINGOLIMOD; UNITED-STATES; ADULTS REPORT; HEADACHE;
D O I
10.1016/j.msard.2012.10.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a highly prevalent neurological condition that commonly affects patients with multiple sclerosis (MS). In this review, we examine the case for a clinical and epidemiological association between migraine and MS and discuss how to diagnose and treat migraine effectively in MS patients. If there is an epidemiologic association between MS and migraine, a causal relationship remains to be demonstrated and the effect-size, at best, appears to be small. Accurate diagnosis of migraine in MS patients is important for improving care by (1) distinguishing symptoms related to MS versus migraine, (2) recognizing that migraineurs have altered sensory perception, which may influence the patient experience of certain MS-related symptoms, such as paresthesias and pain, (3) informing disease modifying therapy selection and (4) optimizing migraine treatment with appropriate preventive and acute therapy. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 80 条
[1]  
Absinta M, 2012, J NEUROLOGY
[2]   Temporal trends in the incidence of multiple sclerosis [J].
Alonso, Alvaro ;
Hernan, Miguel A. .
NEUROLOGY, 2008, 71 (02) :129-135
[3]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[4]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[5]   Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis [J].
Cohen, Jeffrey A. ;
Barkhof, Frederik ;
Comi, Giancarlo ;
Hartung, Hans-Peter ;
Khatri, Bhupendra O. ;
Montalban, Xavier ;
Pelletier, Jean ;
Capra, Ruggero ;
Gallo, Paolo ;
Izquierdo, Guillermo ;
Tiel-Wilck, Klaus ;
de Vera, Ana ;
Jin, James ;
Stites, Tracy ;
Wu, Stacy ;
Aradhye, Shreeram ;
Kappos, Ludwig .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (05) :402-415
[6]  
Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670
[7]   Rate of pregnancy-related relapse in multiple sclerosis [J].
Confavreux, C ;
Hutchinson, M ;
Hours, MM ;
Cortinovis-Tourniaire, P ;
Moreau, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :285-291
[8]   Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial [J].
Cruz, Francisco ;
Herschorn, Sender ;
Aliotta, Philip ;
Brin, Mitchell ;
Thompson, Catherine ;
Lam, Wayne ;
Daniell, Grace ;
Heesakkers, John ;
Haag-Molkenteller, Cornelia .
EUROPEAN UROLOGY, 2011, 60 (04) :742-750
[9]  
Cuomo-Granston A, 2010, PROGR NEUROBIOLOGY, V91, P300
[10]   OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [J].
Diener, H. C. ;
Dodick, D. W. ;
Aurora, S. K. ;
Turkel, C. C. ;
DeGryse, R. E. ;
Lipton, R. B. ;
Silberstein, S. D. ;
Brin, M. F. .
CEPHALALGIA, 2010, 30 (07) :804-814